ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Huntsman Cancer Institute Joins NCCN: Howard cancer Center To Honor Mandela

November 7, 1997

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985